TREM1 and Sepsis: Therapeutic effect of TREM-1 blockade was demonstrated in animal models of sepsis (40, 41), cancer (42–44), acute respiratory distress syndrome (45–47), inflammatory bowel disease (32, 48), rheumatoid arthritis (RA) (49–51), and other inflammation-associated pathologies (52–75).